Ultrasound and clinicopathological characteristics-based model for prediction of pathologic response to neoadjuvant chemotherapy in HER2-positive breast cancer: a case-control study.
Lin SuiYuqi YanTian JiangDi OuChen ChenMin LaiChen NiXi ZhuLiping WangChen YangWei LiJincao YaoDong XuPublished in: Breast cancer research and treatment (2023)
The conventional US combined with clinicopathological characteristics to construct a combined model has a good diagnostic effect in predicting pCR in HER2-positive breast cancer and is expected to be a useful tool to assist clinicians in effectively determining the efficacy of NACT in HER2-positive breast cancer patients.